These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18424164)

  • 1. Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways.
    Gao ZG; Jacobson KA
    Pharmacol Res; 2008 Apr; 57(4):303-11. PubMed ID: 18424164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers.
    Gao ZG; Verzijl D; Zweemer A; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    Biochem Pharmacol; 2011 Sep; 82(6):658-68. PubMed ID: 21718691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives.
    Storme J; Tosh DK; Gao ZG; Jacobson KA; Stove CP
    Biochem Pharmacol; 2018 Dec; 158():103-113. PubMed ID: 30292756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.
    Gao ZG; Balasubramanian R; Kiselev E; Wei Q; Jacobson KA
    Biochem Pharmacol; 2014 Aug; 90(3):297-306. PubMed ID: 24853985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A
    Stoddart LA; Kilpatrick LE; Corriden R; Kellam B; Briddon SJ; Hill SJ
    FASEB J; 2021 Apr; 35(4):e21211. PubMed ID: 33710641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
    Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of regions outside the cytoplasmic tail of G-protein-coupled receptors for phosphorylation and dephosphorylation.
    Gehret AU; Hinkle PM
    Biochem J; 2010 May; 428(2):235-45. PubMed ID: 20345371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of biased agonism at the A
    Pottie E; Tosh DK; Gao ZG; Jacobson KA; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113934. PubMed ID: 32224136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
    Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
    Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
    Taliani S; La Motta C; Mugnaini L; Simorini F; Salerno S; Marini AM; Da Settimo F; Cosconati S; Cosimelli B; Greco G; Limongelli V; Marinelli L; Novellino E; Ciampi O; Daniele S; Trincavelli ML; Martini C
    J Med Chem; 2010 May; 53(10):3954-63. PubMed ID: 20408530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif.
    Chen Z; Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
    J Biol Chem; 2002 Mar; 277(9):7356-62. PubMed ID: 11729201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.
    Emery AC; DiRaddo JO; Miller E; Hathaway HA; Pshenichkin S; Takoudjou GR; Grajkowska E; Yasuda RP; Wolfe BB; Wroblewski JT
    Mol Pharmacol; 2012 Aug; 82(2):291-301. PubMed ID: 22584219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.